4
Changes in Ownership
ENDRA Life Sciences Inc. Filed Acc 0001209191-20-024213
Chief Financial Officer acquired 79,653 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Wells David R. Chief Financial Officer | 2020-04-09 | Grant or award | +79,653 | 99,653 | D: show line 1 in the form |
Loading xslF345X03/doc4.xml…